These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21898383)

  • 1. Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps.
    Soubry A; Il'yasova D; Sedjo R; Wang F; Byers T; Rosen C; Yashin A; Ukraintseva S; Haffner S; D'Agostino R
    Int J Cancer; 2012 Jul; 131(2):512-7. PubMed ID: 21898383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating insulin-like growth factor-related biomarkers: Correlates and responses to calcium supplementation in colorectal adenoma patients.
    Um CY; Fedirko V; Flanders WD; Höflich C; Wirthgen E; Bostick RM
    Mol Carcinog; 2017 Sep; 56(9):2127-2134. PubMed ID: 28467661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas.
    Flood A; Mai V; Pfeiffer R; Kahle L; Rosen CJ; Lanza E; Schatzkin A
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1493-8. PubMed ID: 18559566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men.
    Teramukai S; Rohan T; Lee KY; Eguchi H; Oda T; Kono S
    Jpn J Cancer Res; 2002 Nov; 93(11):1187-94. PubMed ID: 12460458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides.
    Renehan AG; Toogood AA; Ryder WD; Jones J; Potten CS; O'Dwyer ST; Shalet SM
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):469-75. PubMed ID: 11678829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
    Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk colorectal adenomas and serum insulin-like growth factors.
    Renehan AG; Painter JE; Atkin WS; Potten CS; Shalet SM; O'Dwyer ST
    Br J Surg; 2001 Jan; 88(1):107-13. PubMed ID: 11136321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ
    J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.
    Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
    Cancer Epidemiol; 2015 Dec; 39(6):1026-35. PubMed ID: 26388613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating insulin-like growth factor II and colorectal adenomas.
    Renehan AG; Painter JE; O'Halloran D; Atkin WS; Potten CS; O'Dwyer ST; Shalet SM
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3402-8. PubMed ID: 10999841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of IGF-1Ec with increasing colonic polyp dysplasia and colorectal cancer.
    Alagaratnam S; Loizidou M; Yang SY; Fuller B; Ramesh B
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2861-2870. PubMed ID: 32772171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.
    Fuchs CS; Goldberg RM; Sargent DJ; Meyerhardt JA; Wolpin BM; Green EM; Pitot HC; Pollak M
    Clin Cancer Res; 2008 Dec; 14(24):8263-9. PubMed ID: 19073970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women.
    Probst-Hensch NM; Wang H; Goh VH; Seow A; Lee HP; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):739-46. PubMed ID: 12917205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.